1. Partial purification and characterization of an esterase acting on the anticancer pro-drugs, 7-ethylcamptothecin derivatives.
- Author
-
Fujita Y, Yaegashi T, Sawada S, Oyama H, Yoshimoto T, and Tsuru D
- Subjects
- Animals, Camptothecin metabolism, Chromatography, High Pressure Liquid, Esterases antagonists & inhibitors, Esterases metabolism, Irinotecan, Liver enzymology, Male, Pancreas enzymology, Rats, Rats, Wistar, Antineoplastic Agents, Phytogenic metabolism, Camptothecin analogs & derivatives, Esterases isolation & purification, Prodrugs metabolism
- Abstract
A hydrolytic enzyme which catalyzes hydrolysis of the ester-linkage of a series of 17-O-acyl derivatives of 7-ethylcamptothecin-21-(2-dimethylamino)ethylamide [acyl derivatives of 22E] was purified from rat liver and its properties were characterized. It hydrolyzed the ester-linkage of all 22E derivatives tested as well as p-nitrophenyl acetate at pH 8-9 but had no effect on 7-ethyl-10-[4-(piperidino)-1-piperidino] carbonyloxycamptothecin (CPT-11: irinotecan), unlike CPT-11 converting carboxylesterase, which was previously purified from rat serum [Tsuji T. et al., J. Pharmacobio-Dyn., 14, 341 (1991)]. The enzyme had no effect on either acetyl choline or butyrylcholine. It was inhibited by several organophosphorous compounds such as diisopropyl fluorophosphate (DFP), bis-(p-nitrophenyl)phosphate and paraoxon, but was insensitive to inhibitors specific for choline esterases. These results indicate that this liver esterase is clearly distinct from choline esterase and serum CPT-11 converting enzyme and is able to convert pro-drugs, O-acyl derivatives of 22E, to an antitumor agent.
- Published
- 1995
- Full Text
- View/download PDF